BioTech/Drugs - San Diego, CA, US
Cidara (NASDAQ: CDTX) is developing long-acting therapeutics to improve the standard of care for patients facing serious diseases. The Company's portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara's proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.
Outlook
Route 53
Freshdesk
Microsoft Office 365
Google Cloud Hosting
Adobe Marketing Cloud